Schemel Forum, April 16

The Schemel Forum Presents: A Jesuit Education and Integrative Thinking in Biotechnology (fighting Tuberculosis) and Economics (eradicating poverty)

Michael Fairbanks, Ph.D., Fellow at Harvard and the chairman and founder of Akagera Medicines, a Biotech company based in Boston and San Francisco focussed on cures for infectious diseases

The Scranton tradition of “scholarship and service” is only part of it. Taking the best ideas and tools from one academic domain and applying them to the challenges of another is how innovation occurs.

Friday, April 16
Via ZOOM- link will be emailed; Noon to 1:30 p.m.
To register contact Alicen.Morrison@scranton.edu

Free to University of Scranton Staff, Students, Faculty and Schemel Forum Members/ $10 per person